Literature DB >> 17176330

The restricted use of IGHV3 superspecies genes in anti-Rh is not limited to hyperimmunized anti-D donors.

Serge E Dohmen1, Onno J H M Verhagen, Jessica Muit, Peter C Ligthart, C Ellen van der Schoot.   

Abstract

BACKGROUND: Antibodies produced against the D antigen make use of IGHV genes restricted to the IGHV3 superfamily. These findings are based on the IGHV gene analysis in anti-D-producing B cells from hyperimmunized donors, however, and therefore the restriction might be due to the hyperimmunization. In this study the IGHV gene usage of anti-Rh-producing B cells in a woman who was immunized in the last trimester of her pregnancy was analyzed. STUDY DESIGN AND METHODS: Serologic analysis was performed by absorption and elution. Antibody-dependent cellular cytotoxicity (ADCC) of the different anti-Rh was determined. A phage display library was constructed from 2.2 x 10(6) isolated B cells and pannings were performed with red cells of the r'r, R1R1, and R2R2 phenotype.
RESULTS: A plasma sample of the immunized person showed high levels of both anti-D and anti-G and low levels of anti-C. Anti-D and anti-G contributed equally strong to the ADCC whereas anti-C did not. Eighteen anti-D-, 5 anti-G-, and 1 anti-C-specific phage clones were found, of which 16, 2, and 1 used the IGHV3s genes, respectively.
CONCLUSION: For the first time a restriction to the IGHV3s genes in anti-D in a naturally immunized pregnant woman is shown. Moreover, the use of IGHV3s genes appears to be present in anti-C and anti-G as well. Therefore, it is concluded that restricted IGHV3s gene usage in anti-D is not due to hyperimmunization but due to characteristics of the Rh antigens and the intrinsic binding capacities of IGHV3s genes, supporting the common Rh footprint hypothesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176330     DOI: 10.1111/j.1537-2995.2006.01047.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Aggregates in blood filter chambers used from the plasma donations of anti-D donors: evaluation for monoclonal antibody discovery using phage display.

Authors:  Eunike C McGowan; Robert L Flower; Martina L Jones; David O Irving; Ross T Barnard; Catherine A Hyland; Stephen M Mahler; Xuan T Bui
Journal:  Blood Transfus       Date:  2020-10-09       Impact factor: 3.443

Review 2.  Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies.

Authors:  Pauline A van Schouwenburg; Simone Kruithof; Christian Votsmeier; Karin van Schie; Margreet H Hart; Rob N de Jong; Esther E L van Buren; Marieke van Ham; Lucien Aarden; Gertjan Wolbink; Diana Wouters; Theo Rispens
Journal:  J Biol Chem       Date:  2014-10-17       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.